BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, Dickerson JA, Drees JC, Humble RM, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy. J Appl Lab Med 2021;6:15-26. [PMID: 32674116 DOI: 10.1093/jalm/jfaa028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Bezuidenhout M, Conradie-smit M, de Vries E, Dave J, Ross I, Zemlin A. Correspondence: Role of clinical laboratories in reporting results of transgender individuals on hormonal therapy by Phiri-Ramongane and Khine. Journal of Endocrinology, Metabolism and Diabetes of South Africa 2022;27:131-132. [DOI: 10.1080/16089677.2022.2079819] [Reference Citation Analysis]
2 Moya-Salazar J, Cerda SP, Cañari B, Moya-Salazar MM, Contreras-Pulache H. Reference intervals of the sex hormonal profile in healthy women: A retrospective single-center study in Peru. Heliyon 2022;8:e10592. [PMID: 36119895 DOI: 10.1016/j.heliyon.2022.e10592] [Reference Citation Analysis]
3 Haben CM. Gender-Affirming Hormone Therapy: What the Head and Neck Surgeon Should Know. Otolaryngol Clin North Am 2022:S0030-6665(22)00036-6. [PMID: 35752491 DOI: 10.1016/j.otc.2022.04.002] [Reference Citation Analysis]
4 Bezuidenhout MC, Conradie-Smit M, Dave JA, de Vries E, Ross IL, Zemlin AE. Reference intervals for biochemical analytes in transgender individuals on hormone therapy. Ann Clin Biochem 2022;59:183-92. [PMID: 35044249 DOI: 10.1177/00045632211066777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Le A, Huang KJ, Cirrincione LR. Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine. Trends Pharmacol Sci 2022:S0165-6147(22)00056-6. [PMID: 35487786 DOI: 10.1016/j.tips.2022.03.006] [Reference Citation Analysis]
6 Balcerek MI, Nolan BJ, Brownhill A, Wong P, Locke P, Zajac JD, Cheung AS. Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia. Front Endocrinol (Lausanne) 2021;12:667403. [PMID: 34326812 DOI: 10.3389/fendo.2021.667403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Schneider F, Dabel J, Sandhowe-Klaverkamp R, Neuhaus N, Schlatt S, Kliesch S, Wistuba J. Serum and intratesticular inhibin B, AMH, and spermatogonial numbers in trans women at gender-confirming surgery: An observational study. Andrology 2021. [PMID: 34085780 DOI: 10.1111/andr.13059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Cirrincione LR, Huang KJ. Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine. Clin Pharmacol Ther 2021;110:897-908. [DOI: 10.1002/cpt.2234] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
9 Cirrincione LR, Huang KJ. Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine. Clin Pharmacol Ther 2021;110:897-908. [PMID: 33763856 DOI: 10.1002/cpt.2234] [Cited by in F6Publishing: 1] [Reference Citation Analysis]